Abstract

Lung metastases occur in 20-60% of cases during the natural course of managing cancers. This wide range depends on tumour histology, biological behaviour, clinical stage at diagnosis, type of control of the primary disease, and response to treatment. All this requires the establishment of a thoracic oncology group that is highly familiar with the treatment and behaviour of the primary tumour in order to provide control of secondary lung metastases. There is sufficient evidence to demonstrate that multidisciplinary management of lung metastases is now the best way to improve disease-free survival and increase overall survival with adequate lung function and quality of life.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call